A potential hidden source of hepatitis C infection among noninjecting drug users.
Hepatitis C virus (HCV) is a major cause of chronic liver disease in the United States and worldwide. It is primarily transmitted through blood-to-blood contact with an infected individual. HCV is hyperendemic among injection drug users (IDUs), who contract the virus through contaminated syringes and drug preparation equipment shared with other IDUs. The prevalence of HCV is also high, to a lesser degree, among noninjection drug users, many of whom report no identifiable HCV risk exposures. This article reviews the epidemiological and virological evidence bearing on a potential hidden source of HCV infection among noninjection drug users: namely, the oral or intranasal transmission of HCV through the sharing of noninjection drug-use implements such as pipes or straws. While there is some epidemiological evidence supporting both oral and intranasal HCV transmission, most studies are hampered by methodological limitations. Thus, there is a need for prospective studies designed specifically to examine these potential routes of transmission. Current biological evidence does not refute either oral or intranasal transmission as possible sources of HCV infection, although more research is needed in the areas of oronasal HCV pathogenesis and the detection of HCV RNA in the nasal mucosa of intranasal drug users.
National Development and Research Institutes, New York, New York 10010, USA. mcmahon@ndri.org
James M
JM
McMahon
Stephanie
S
Tortu
D000281:Administration, Intranasal; D000284:Administration, Oral; D016174:Hepacivirus; D006526:Hepatitis C / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D019966:Substance-Related Disorders / Q000150:complications* / Q000453:epidemiology